A Study of LY4088044 in Healthy Participants
Phase 1
104
about 2 years
18–65
4 sites in CA, KS, TX +1
About this study
This trial is testing a new drug called LY4088044 to see how well it's tolerated and what side effects might occur. The drug will be given either under the skin or into a vein, and blood tests will monitor its levels and elimination from the body. It lasts up to 92 weeks.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take LY4088044
- 2.Take Placebo
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Primary: Number of Participants with One or More Serious Adverse Event(s) (SAEs) Considered by the Investigator to be Related to Study Drug Administration
Secondary: PK: Area Under the Concentration Versus Time Curve (AUC) of LY4088044, Pharmacodynamics (PD): Protein Levels in Skin Samples, Pharmacokinetics (PK): Maximum Concentration (Cmax) of LY4088044